[go: up one dir, main page]

WO2002061432A3 - Gpr22, recepteur couple aux proteines g (gpcr) et compositions et procedes associes a ce recepteur - Google Patents

Gpr22, recepteur couple aux proteines g (gpcr) et compositions et procedes associes a ce recepteur Download PDF

Info

Publication number
WO2002061432A3
WO2002061432A3 PCT/US2001/051388 US0151388W WO02061432A3 WO 2002061432 A3 WO2002061432 A3 WO 2002061432A3 US 0151388 W US0151388 W US 0151388W WO 02061432 A3 WO02061432 A3 WO 02061432A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhibition
treatment
diagnosis
compositions
gpr22
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/051388
Other languages
English (en)
Other versions
WO2002061432A2 (fr
Inventor
Glenna C Burmer
Christina L Roush
Joseph P Brown
Madeline L Woodward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeSpan BioSciences Inc
Original Assignee
LifeSpan BioSciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeSpan BioSciences Inc filed Critical LifeSpan BioSciences Inc
Publication of WO2002061432A2 publication Critical patent/WO2002061432A2/fr
Publication of WO2002061432A3 publication Critical patent/WO2002061432A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention se rapporte à des systèmes, des procédés, des compositions et analogues telles que des compositions de diagnostic, des médicaments et des agents thérapeutiques, associés au GPR22, lesdites compositions comportant les séquences d'acides nucléiques et de polypeptides indiquées dans la description comme associées au GPR22. La présente invention se rapporte également au diagnostic, au traitement ou à l'inhibition de carcinomes, du type mélanome malin, carcinome du colon, carcinome de la prostate, carcinome ovarien, glioblastome multiforme et maladie de Hodgkin, ainsi qu'au diagnostic, au traitement ou à l'inhibition de myocytes cardiaques lésionnés, notamment ceux associés au diabète ou à l'infarctus du myocarde, au diagnostic, au traitement ou à l'inhibition des troubles du poumon, notamment des emphysèmes, des pneumonies et de l'asthme, au diagnostic, au traitement ou à l'inhibition de la maladie de Crohn, et au diagnostic, au traitement ou à l'inhibition de la polyarthrite rhumatoïde.
PCT/US2001/051388 2001-02-01 2002-02-01 Gpr22, recepteur couple aux proteines g (gpcr) et compositions et procedes associes a ce recepteur Ceased WO2002061432A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26594001P 2001-02-01 2001-02-01
US60/265,940 2001-02-01

Publications (2)

Publication Number Publication Date
WO2002061432A2 WO2002061432A2 (fr) 2002-08-08
WO2002061432A3 true WO2002061432A3 (fr) 2003-01-30

Family

ID=23012502

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/051388 Ceased WO2002061432A2 (fr) 2001-02-01 2002-02-01 Gpr22, recepteur couple aux proteines g (gpcr) et compositions et procedes associes a ce recepteur

Country Status (2)

Country Link
AU (1) AU2002239800A1 (fr)
WO (1) WO2002061432A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100473662C (zh) 2002-08-01 2009-04-01 阿瑞那制药公司 治疗缺血性心脏病及充血性心衰竭的人类g蛋白偶联受体及其调节物
US20080260744A1 (en) 2002-09-09 2008-10-23 Omeros Corporation G protein coupled receptors and uses thereof
WO2005047905A1 (fr) * 2003-10-28 2005-05-26 Bayer Healthcare Ag Diagnostic et therapie de maladies associees au recepteur 22 couple a la proteine g (gpr22)
WO2008061209A2 (fr) * 2006-11-15 2008-05-22 Omeros Corporation Récepteurs couplés à la protéine g et leurs utilisations
EP2133433A1 (fr) * 2008-06-09 2009-12-16 Centre Georges François Leclerc Procédé de prédiction de la réactivité à un traitement avec un anticorps anti-HER2

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052204A2 (fr) * 1999-02-22 2000-09-08 Orntoft Torben F Expression genique dans les tumeurs de la vessie
WO2001030964A2 (fr) * 1999-10-22 2001-05-03 Lifespan Biosciences, Inc. Acides nucleiques anticancereux et cibles proteiniques
WO2001083550A2 (fr) * 2000-05-03 2001-11-08 Astrazeneca Ab Procedes
WO2002006445A2 (fr) * 2000-07-19 2002-01-24 Deltagen, Inc. Souris transgenique contenant des disruptions geniques ciblees

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994097A (en) 1997-08-28 1999-11-30 Incyte Pharmaceuticals, Inc. Polynucleotide encoding human G-protein coupled receptor

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052204A2 (fr) * 1999-02-22 2000-09-08 Orntoft Torben F Expression genique dans les tumeurs de la vessie
WO2001030964A2 (fr) * 1999-10-22 2001-05-03 Lifespan Biosciences, Inc. Acides nucleiques anticancereux et cibles proteiniques
WO2001083550A2 (fr) * 2000-05-03 2001-11-08 Astrazeneca Ab Procedes
WO2002006445A2 (fr) * 2000-07-19 2002-01-24 Deltagen, Inc. Souris transgenique contenant des disruptions geniques ciblees

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
O'DOWD B F ET AL: "Cloning and chromosomal mapping of four putative novel human G-protein-coupled receptor genes", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 187, no. 1, 10 March 1997 (1997-03-10), pages 75 - 81, XP004093242, ISSN: 0378-1119 *

Also Published As

Publication number Publication date
WO2002061432A2 (fr) 2002-08-08
AU2002239800A1 (en) 2002-08-12

Similar Documents

Publication Publication Date Title
CN100447136C (zh) 螺三环衍生物及其作为磷酸二酯酶-7抑制剂的应用
DE69529172T2 (de) Zyklische hexapeptide mit antibiotischer aktivität
HK1054333A1 (zh) 杂芳基脲神经肽yy5受体拮抗剂
WO2002061087A3 (fr) Peptides antigeniques destines a des recepteurs couples a la proteine g (gpcr), anticorps s'y rapportant, et systeme d'identification desdits peptides antigeniques
IL173029A0 (en) Imaging agents
WO2003082191A3 (fr) 2,3-diphenyl-pyridines substituees
WO2004082599A3 (fr) Combinaison d'un antagoniste de recepteur d'aldosterone et d'un agent anti-diabetique
WO2004093908A3 (fr) Compositions et techniques destinees a la therapie d'une maladie intestinale inflammatoire
WO2002061432A3 (fr) Gpr22, recepteur couple aux proteines g (gpcr) et compositions et procedes associes a ce recepteur
EP1398029A8 (fr) Derivés de pyrazole,substitués en position 3 ayant une affinité envers le NR3B1 récepteur
EP0892051A3 (fr) Clone heoad54 de CADN codant pour un récepteur 7-transmembranaire humaine
WO2001097860A3 (fr) Produits pharmaceutiques pour l'imagerie de troubles angiogeniques
WO2001051095A3 (fr) Derives paramagnetiques de type dota, agents pharmaceutiques les contenant, procedes permettant de les preparer et leur utilisation pour l'imagerie par resonance magnetique de necroses et de l'infarctus
WO2003088924A3 (fr) Inhibition des gpcr induite par la phosphoinositide 3-kinase
EP0913471A3 (fr) Clone HNEAA81 de CADN codant pour un récepteur 7-transmembranaire humain
WO2000073343A3 (fr) Nouvelles utilisations d'anticorps contre la douleur et peptides associes
WO2000050596A3 (fr) Recepteur 14273, un nouveau recepteur couple a la proteine g
WO2002083736A3 (fr) Molecules du recepteur couple aux proteines g et utilisation desdites molecules
WO2005040828A3 (fr) Agents de diagnostic et de traitement des maladies associees au recepteur 49 couple aux proteines g (gpr49)
EP1199308A3 (fr) Procédé pour la préparation d'intermédiaires de l'imidazodiazépine
EP0878542A3 (fr) Clone HMTMF81 de cADN codant pour un nouveau récepteur 7-transmembranaire humain
WO2005059546A3 (fr) Diagnostics et therapeutique destines au traitement de maladies associees au recepteur couple aux proteines g 35 (gpr35)
WO2005040822A3 (fr) Diagnostics et therapeutiques pour des maladies associees au recepteur 25 couple a la proteine g (gpr25)
WO2005040829A3 (fr) Agents de diagnostic et de traitement des maladies associees au recepteur 17 couple aux proteines g (gpr17)
WO2004099248A3 (fr) Produits de diagnostic et de traitement de maladies associees au recepteur agtr2 couple aux proteines g (agtr2)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC (EPO FORM 1205A DATED 02-11-2004

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP